Medical Developments International has released a press release.
FY26 Half Year Report (including Appendix 4D)
Earlier from Medical Developments International
- Appendix 4C and Quarterly Activity Report 31 December 2025
- Vaxxas Appoints Former Merck Global Vaccines President David Peacock as CEO
- Vaxxas Appoints Veteran Vaccine Leader to Board as Company Advances Needle-Free Vaccine Patch Towards Market
- Appendix 4C and Quarterly Activity Report 30 September2025